ENT in a project addressing one of the most complex questions in contemporary medicine

At a congress held in Florence at the end of March, Luka Jelić, a doctoral candidate at the Faculty of Electrical Engineering and Computing and an employee of Ericsson Nikola Tesla, presented the continuation of research for which Pavo Orepić, a neuroscientist from Ploče and a postdoctoral researcher at the University of Zurich, received international recognition.

Pavo Orepić is the recipient of the Early Career Award granted by the world’s leading organization for research in the field of schizophrenia and psychosis. His research, initiated in Switzerland, has been expanded to Croatia through the involvement of the University Psychiatric Hospital Vrapče, the Faculty of Electrical Engineering and Computing, and Ericsson Nikola Tesla. In this way, Croatian institutions have become part of cutting‑edge clinical research in psychiatry and neuroscience. The research contributes to a better understanding of psychosis and paves the way for the development of tools that could support physicians in the future. This international cooperation, which brings advanced clinical research to Croatia, has connected ENT, the hospital, the faculty and the Swiss scientific center.

Luka Jelić from ENT, who conducted the Zagreb part of the research in cooperation with physicians from the University Psychiatric Hospital Vrapče, presented at the aforementioned congress in Florence a project that uses machine learning to distinguish healthy participants from patients with schizophrenia based on voice.

Participation in this project is part of ENT’s ongoing efforts to enhance the quality and competitiveness of domestic scientific research through cooperation with Croatian and international partners on projects that push the boundaries of modern science.

Communications Ericsson Nikola Tesla